MX2009009636A - Metodos para tratar enfermedades oftalmicas. - Google Patents
Metodos para tratar enfermedades oftalmicas.Info
- Publication number
- MX2009009636A MX2009009636A MX2009009636A MX2009009636A MX2009009636A MX 2009009636 A MX2009009636 A MX 2009009636A MX 2009009636 A MX2009009636 A MX 2009009636A MX 2009009636 A MX2009009636 A MX 2009009636A MX 2009009636 A MX2009009636 A MX 2009009636A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- ophthalmic diseases
- treating ophthalmic
- treating
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Se describen métodos para usar inhibidores (incluyendo anticuerpos monoclonales) dirigidos contra el péptido amiloide-beta para el tratamiento de enfermedades oftálmicas tales como degeneración macular relacionada con la edad.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US89418107P | 2007-03-09 | 2007-03-09 | |
US12/041,581 US20090022728A1 (en) | 2007-03-09 | 2008-03-03 | Methods of treating ophthalmic diseases |
PCT/IB2008/000486 WO2008110885A2 (en) | 2007-03-09 | 2008-03-06 | Methods of treating ophthalmic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009009636A true MX2009009636A (es) | 2009-12-11 |
Family
ID=39760152
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009009636A MX2009009636A (es) | 2007-03-09 | 2008-03-06 | Metodos para tratar enfermedades oftalmicas. |
Country Status (15)
Country | Link |
---|---|
US (1) | US20090022728A1 (es) |
EP (1) | EP2134751A2 (es) |
JP (2) | JP5964004B2 (es) |
KR (2) | KR101259225B1 (es) |
CN (2) | CN101687922B (es) |
AU (1) | AU2008224600B2 (es) |
BR (1) | BRPI0808711A2 (es) |
CA (1) | CA2680222C (es) |
HK (1) | HK1201046A1 (es) |
IL (1) | IL200528A0 (es) |
MX (1) | MX2009009636A (es) |
NZ (1) | NZ579273A (es) |
RU (1) | RU2434639C2 (es) |
TW (1) | TWI449535B (es) |
WO (1) | WO2008110885A2 (es) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
PL1954718T3 (pl) | 2005-11-30 | 2015-04-30 | Abbvie Inc | Przeciwciała skierowane przeciwko A globulomerowi, ich reszty wiążące antygeny, odpowiednie hybrydomy, kwasy nukleinowe, wektory, komórki gospodarze, sposoby wytwarzania tych przeciwciał, kompozycje zawierające te przeciwciała, zastosowania tych przeciwciał i sposoby stosowania tych przeciwciał |
JP5486808B2 (ja) | 2005-11-30 | 2014-05-07 | アッヴィ・インコーポレイテッド | アミロイドベータタンパク質に対するモノクローナル抗体及びその使用 |
PL2046833T3 (pl) | 2006-07-14 | 2014-01-31 | Ac Immune Sa | Humanizowane przeciwciało przeciw amyloidowi beta |
US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
US8048420B2 (en) | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
AU2015200604B2 (en) * | 2007-10-05 | 2016-10-27 | Ac Immune S.A. | Use of anti-amyloid beta antibody in ocular diseases |
CN105169388A (zh) * | 2007-10-05 | 2015-12-23 | 基因技术公司 | 人源化抗体 |
CN101998863B (zh) * | 2007-10-05 | 2015-09-16 | 基因技术公司 | 抗淀粉状蛋白β抗体在眼病中的用途 |
RS53174B (en) | 2007-10-05 | 2014-06-30 | Genentech Inc. | USE OF ANTIAMYLOID BETA ANTIBODY IN THE EVENT OF ANY DISEASE |
BRPI0819916A2 (pt) | 2007-12-11 | 2015-05-19 | Glaxo Group Ltd | Proteína de ligação a antígeno, composição farmacêutica, método para tratar um paciente humano afligido com uma doença, anticorpo ou fragmento do mesmo, e, proteína de ligação a antígeno. |
CN104744591B (zh) | 2010-04-15 | 2022-09-27 | Abbvie德国有限责任两合公司 | β淀粉样蛋白结合蛋白 |
WO2012016173A2 (en) | 2010-07-30 | 2012-02-02 | Ac Immune S.A. | Safe and functional humanized antibodies |
CN105348387B (zh) | 2010-08-14 | 2020-08-25 | Abbvie 公司 | β淀粉样蛋白结合蛋白 |
JP2014511174A (ja) * | 2011-02-07 | 2014-05-15 | ネオトープ バイオサイエンシーズ リミテッド | Apoe免疫療法 |
RU169012U1 (ru) * | 2016-08-08 | 2017-03-01 | Дмитрий Викторович Давыдов | Электрод для электростимуляции зрительного нерва и зрительных путей и контроля физиологических параметров орбитальных структур глаза |
WO2018200620A1 (en) * | 2017-04-25 | 2018-11-01 | National Cheng Kung University | Use of il-20 antagonists for treating eye diseases |
CA3161266A1 (en) * | 2019-12-09 | 2021-06-17 | Alexion Pharmaceuticals, Inc. | Alkaline phosphatase polypeptides and methods of use thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004032868A2 (en) * | 2002-10-09 | 2004-04-22 | Rinat Neuroscience Corp. | Methods of treating alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
JP2007527865A (ja) * | 2003-09-12 | 2007-10-04 | ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア | 種々の配列を有するタンパク質から形成されたアミロイドに共通の高分子量凝集中間体に特異的なモノクローナル抗体 |
US20060121039A1 (en) * | 2004-12-07 | 2006-06-08 | Alcon, Inc. | Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration |
EP2298807A3 (en) * | 2004-07-30 | 2011-05-18 | Rinat Neuroscience Corp. | Antibodies directed against amyloid-beta peptide and methods using same |
WO2006039327A2 (en) * | 2004-10-01 | 2006-04-13 | Merck & Co., Inc. | Methods of treatment or prophylaxis of amyloidogenic diseases of the eye or optic nerve |
JP2008527005A (ja) * | 2005-01-14 | 2008-07-24 | ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、カリフォルニア | ドルーゼン形成を阻害するため、およびドルーゼン関連障害を診断または治療するための組成物および方法 |
UY29504A1 (es) * | 2005-04-29 | 2006-10-31 | Rinat Neuroscience Corp | Anticuerpos dirigidos contra el péptido amiloide beta y métodos que utilizan los mismos. |
DK2361638T3 (en) * | 2005-12-12 | 2014-03-03 | Ac Immune Sa | Beta-1-42-specific monoclonal antibodies with therapeutic properties |
PL2046833T3 (pl) * | 2006-07-14 | 2014-01-31 | Ac Immune Sa | Humanizowane przeciwciało przeciw amyloidowi beta |
ES2640095T3 (es) * | 2006-10-02 | 2017-10-31 | Ac Immune S.A. | Anticuerpo humanizado contra beta-amiloide |
-
2008
- 2008-03-03 US US12/041,581 patent/US20090022728A1/en not_active Abandoned
- 2008-03-06 RU RU2009133789/15A patent/RU2434639C2/ru not_active IP Right Cessation
- 2008-03-06 EP EP08737296A patent/EP2134751A2/en not_active Withdrawn
- 2008-03-06 BR BRPI0808711-3A patent/BRPI0808711A2/pt not_active IP Right Cessation
- 2008-03-06 MX MX2009009636A patent/MX2009009636A/es active IP Right Grant
- 2008-03-06 CN CN200880007669.6A patent/CN101687922B/zh not_active Expired - Fee Related
- 2008-03-06 AU AU2008224600A patent/AU2008224600B2/en not_active Ceased
- 2008-03-06 WO PCT/IB2008/000486 patent/WO2008110885A2/en active Application Filing
- 2008-03-06 CA CA2680222A patent/CA2680222C/en not_active Expired - Fee Related
- 2008-03-06 KR KR1020097021056A patent/KR101259225B1/ko not_active IP Right Cessation
- 2008-03-06 KR KR1020127010798A patent/KR20120054105A/ko not_active Application Discontinuation
- 2008-03-06 NZ NZ579273A patent/NZ579273A/en not_active IP Right Cessation
- 2008-03-06 CN CN201410211278.3A patent/CN104027803A/zh active Pending
- 2008-03-07 TW TW097108208A patent/TWI449535B/zh not_active IP Right Cessation
- 2008-03-10 JP JP2008059313A patent/JP5964004B2/ja not_active Expired - Fee Related
-
2009
- 2009-08-20 IL IL200528A patent/IL200528A0/en unknown
-
2014
- 2014-10-01 JP JP2014202802A patent/JP2015038109A/ja not_active Withdrawn
-
2015
- 2015-02-12 HK HK15101561.0A patent/HK1201046A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
KR20090119990A (ko) | 2009-11-23 |
IL200528A0 (en) | 2010-04-29 |
US20090022728A1 (en) | 2009-01-22 |
JP2009062358A (ja) | 2009-03-26 |
JP2015038109A (ja) | 2015-02-26 |
RU2009133789A (ru) | 2011-03-20 |
KR101259225B1 (ko) | 2013-04-30 |
TWI449535B (zh) | 2014-08-21 |
CN101687922A (zh) | 2010-03-31 |
AU2008224600B2 (en) | 2011-09-29 |
KR20120054105A (ko) | 2012-05-29 |
CA2680222A1 (en) | 2008-09-18 |
HK1201046A1 (en) | 2015-08-21 |
CA2680222C (en) | 2013-10-08 |
RU2434639C2 (ru) | 2011-11-27 |
NZ579273A (en) | 2012-03-30 |
WO2008110885A2 (en) | 2008-09-18 |
CN101687922B (zh) | 2014-06-11 |
BRPI0808711A2 (pt) | 2014-08-12 |
TW200900079A (en) | 2009-01-01 |
WO2008110885A3 (en) | 2009-01-15 |
JP5964004B2 (ja) | 2016-08-03 |
AU2008224600A1 (en) | 2008-09-18 |
EP2134751A2 (en) | 2009-12-23 |
CN104027803A (zh) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009009636A (es) | Metodos para tratar enfermedades oftalmicas. | |
GEP20227369B (en) | Antibodies specific for hyperphosphorylated tau and methods of use thereof | |
SG194701A1 (en) | Anti-cd40 antibodies and methods of use | |
MY156662A (en) | Amine derivative compounds for treating ophthalmic diseases and disorders | |
EP2582722A4 (en) | ANTIBODIES AGAINST GD2 | |
MX2018010331A (es) | Agentes de ligacion al factor de crecimiento endotelial vascular/ligando 4 similar a delta (vegf/dll4) y usos de los mismos. | |
IL187594A0 (en) | Humanized anti-cd40 antibodies and their methods of use | |
NZ706377A (en) | Il-6 antagonists and uses thereof | |
EA200802182A1 (ru) | Модифицированные гуманизированные антитела против интерлейкина-18 | |
PH12015502017A1 (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune disease | |
SG171690A1 (en) | Treatment of protein degradation disorders | |
NO20083002L (no) | Fremgangsmate for anvendelse av CD40-bindende forbindelser | |
MY149630A (en) | Antibodies against amyloid-beta peptide | |
EA200971077A1 (ru) | Гетероциклические модуляторы киназы | |
TN2012000555A1 (en) | Antibodies to human gdf8 | |
WO2007056540A3 (en) | Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy | |
MX2010005651A (es) | Inhibicion de receptor de proteina de estimulacion de macrofagos (ron) y sus metodos de tratamiento. | |
MX350355B (es) | Composiciones y metodos para aumentar la masa muscular y la fuerza muscular antagonizando especificamente gdf8 y/o activina a. | |
MX2022008523A (es) | Compuestos que interactuan con glicanos y metodos de uso. | |
EA201170590A1 (ru) | Ингибиторы рецептора фактора роста фибробластов-3 (fgfr-3) и способы лечения | |
EA200970403A1 (ru) | Бициклические триазолы в качестве модуляторов протеинкиназы | |
WO2007098122A3 (en) | Methods for the treatment of macular degeneration and related eye conditions | |
EA201390156A1 (ru) | ПРОИЗВОДСТВО ИНТЕР-АЛЬФА-ИНГИБИТОРНЫХ БЕЛКОВ (IaIp) ИЗ ПЛАЗМЫ | |
MY153738A (en) | Sulphur-linked compounds for treating ophthalmic diseases and disorders. | |
AU2016348418A8 (en) | Compositions comprising IL6R antibodies for the treatment of uveitis and macular edema and methods of using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FG | Grant or registration |